Finally, we show that immunocompetent syngeneic mice treated with systemic administration of IL13-BBζ CAR T cells after lymphodepleting irradiation exhibit no evidence of off-tumor toxicity and mediate potent antitumor activity in murine orthotopic glioma models. This evidence concerns the gene IL13 and central nervous system cancer.